{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:19:42Z","timestamp":1790983182743,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ejmech.2019.111730","type":"journal-article","created":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T09:28:35Z","timestamp":1569144515000},"page":"111730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Synthesis and biological evaluation of [18F](2S,4S)4-(3-fluoropropyl) arginine as a tumor imaging agent"],"prefix":"10.1016","volume":"183","author":[{"given":"Renbo","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuli","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebo","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zequn","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.111730_bib1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10555-008-9154-7","article-title":"Non-natural amino acids for tumor imaging using positron emission tomography and single photon emission computed tomography","volume":"27","author":"McConathy","year":"2008","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ejmech.2019.111730_bib2","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/med.20250","article-title":"Radiohalogenated nonnatural amino acids as PET and SPECT tumor imaging agents","volume":"32","author":"McConathy","year":"2012","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2019.111730_bib3","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2967\/jnumed.112.113100","article-title":"Radiolabeled amino acids for oncologic imaging","volume":"54","author":"Huang","year":"2013","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ejmech.2019.111730_bib4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2967\/jnumed.116.182345","article-title":"Metabolic imaging of glutamine in cancer","volume":"58","author":"Zhu","year":"2017","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ejmech.2019.111730_bib5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s11307-013-0711-2","article-title":"Imaging tumour ATB0,+ transport activity by PET with the cationic amino acid O-2((2-[18F]fluoroethyl)methyl-amino)ethyltyrosine","volume":"16","author":"Muller","year":"2014","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.ejmech.2019.111730_bib6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00424-003-1146-4","article-title":"The glutamate\/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects","volume":"447","author":"Kanai","year":"2004","journal-title":"Pfl\u00fcg. Arch."},{"key":"10.1016\/j.ejmech.2019.111730_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03066-6","article-title":"Structural basis for amino acid transport by the CAT family of SLC7 transporters","volume":"9","author":"Jungnickel","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2019.111730_bib8","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00424-002-0973-z","article-title":"Heteromeric exchangers of large, neutral amino acids involved in directional transport","volume":"445","author":"Verrey","year":"2003","journal-title":"Pfl\u00fcg. Arch."},{"key":"10.1016\/j.ejmech.2019.111730_bib9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00232-006-0875-7","article-title":"Structure and function of cationic amino acid transporters (CATs)","volume":"213","author":"Closs","year":"2006","journal-title":"J.\u00a0Membr. Biol."},{"key":"10.1016\/j.ejmech.2019.111730_bib10","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1002\/jps.22576","article-title":"Solute carrier transporters as targets for drug delivery and pharmacological intervention for chemotherapy","volume":"100","author":"Nakanishi","year":"2011","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.ejmech.2019.111730_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pharmthera.2008.09.005","article-title":"Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond","volume":"121","author":"Ganapathy","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2019.111730_bib12","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1021\/jm502023y","article-title":"Synthesis, radiolabeling, and biological evaluation of (R)- and (S)-2-Amino-5-[(18)F]fluoro-2-methylpentanoic acid ((R)-, (S)-[(18)F]FAMPe) as potential positron emission tomography tracers for brain tumors","volume":"58","author":"Bouhlel","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111730_bib13","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1021\/acs.jmedchem.6b00189","article-title":"Effect of alpha-methyl versus alpha-hydrogen substitution on brain availability and tumor imaging properties of heptanoic [F-18]Fluoroalkyl amino acids for positron emission tomography (PET)","volume":"59","author":"Bouhlel","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111730_bib14","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.1021\/acs.jmedchem.6b00057","article-title":"Synthesis, radiolabeling, and biological evaluation of 5-hydroxy-2-[(18)F]fluoroalkyl-tryptophan analogues as potential PET radiotracers for tumor imaging","volume":"59","author":"Chiotellis","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111730_bib15","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/bjc.1991.475","article-title":"Uptake of 11C-methionine in breast cancer studied by PET. An association with the size of S-phase fraction","volume":"64","author":"Leskinen-Kallio","year":"1991","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ejmech.2019.111730_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11307-007-0115-2","article-title":"11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas","volume":"10","author":"Singhal","year":"2008","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.ejmech.2019.111730_bib17","doi-asserted-by":"crossref","first-page":"856","DOI":"10.2967\/jnumed.110.086645","article-title":"O-(2-18F-fluoroethyl)-L-tyrosine PET predicts failure of antiangiogenic treatment in patients with recurrent high-grade glioma","volume":"52","author":"Hutterer","year":"2011","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ejmech.2019.111730_bib18","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.nucmedbio.2009.05.005","article-title":"Comparison of 18F-FET and 18F-FDG PET in brain tumors","volume":"36","author":"Pauleit","year":"2009","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ejmech.2019.111730_bib19","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1007\/s00259-007-0534-y","article-title":"FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading","volume":"34","author":"P\u00f6pperl","year":"2007","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ejmech.2019.111730_bib20","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.2967\/jnumed.109.065664","article-title":"18F-FDOPA: a multiple-target molecule","volume":"50","author":"Minn","year":"2009","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ejmech.2019.111730_bib21","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1111\/j.1460-9568.2007.05580.x","article-title":"Striatal dopaminergic activity (FDOPA-PET) associated with cognitive items of a depression scale (MADRS) in Parkinson\u2019s disease","volume":"25","author":"Koerts","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejmech.2019.111730_bib22","first-page":"374","article-title":"Comparison of O-(2-18F-fluoroethyl)-L-tyrosine PET and 3-123I-iodo-alpha-methyl-L-tyrosine SPECT in brain tumors","volume":"45","author":"Pauleit","year":"2004","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ejmech.2019.111730_bib23","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.nucmedbio.2012.03.007","article-title":"Synthesis and evaluation of 18F labeled alanine derivatives as potential tumor imaging agents","volume":"39","author":"Wang","year":"2012","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ejmech.2019.111730_bib24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2967\/jnumed.111.093831","article-title":"Preparation and characterization of L-[5-11C]-glutamine for metabolic imaging of tumors","volume":"53","author":"Qu","year":"2012","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ejmech.2019.111730_bib25","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1021\/ja109203d","article-title":"Synthesis of optically pure 4-fluoro-glutamines as potential metabolic imaging agents for tumors","volume":"133","author":"Qu","year":"2011","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2019.111730_bib26","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.2967\/jnumed.111.101279","article-title":"Comparative evaluation of 18F-labeled glutamic acid and glutamine as tumor metabolic imaging agents","volume":"53","author":"Ploessl","year":"2012","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ejmech.2019.111730_bib27","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1021\/mp500236y","article-title":"[(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent","volume":"11","author":"Wu","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2019.111730_bib28","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1148\/radiol.13130240","article-title":"Localized prostate cancer detection with (18)F FACBC PET\/CT: comparison with MR imaging and histopathologic analysis","volume":"270","author":"Turkbey","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.ejmech.2019.111730_bib29","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1021\/jm010241x","article-title":"Radiolabeled amino acids for tumor imaging with PET: radiosynthesis and biological evaluation of 2-amino-3-[18F]fluoro-2-methylpropanoic acid and 3-[18F]fluoro-2-methyl-2-(methylamino)propanoic acid","volume":"45","author":"McConathy","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111730_bib30","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2967\/jnumed.112.112581","article-title":"(S)-4-(3-18F-fluoropropyl)-L-glutamic acid: an 18F-labeled tumor-specific probe for PET\/CT imaging--dosimetry","volume":"54","author":"Smolarz","year":"2013","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ejmech.2019.111730_bib31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2967\/jnumed.111.096859","article-title":"Performance of 18F-fluoro-ethyl-tyrosine (18F-FET) PET for the differential diagnosis of primary brain tumor: a systematic review and metaanalysis","volume":"53","author":"Dunet","year":"2012","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ejmech.2019.111730_bib32","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.2967\/jnumed.110.078592","article-title":"Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas","volume":"51","author":"Fueger","year":"2010","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ejmech.2019.111730_bib33","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1021\/acs.molpharmaceut.8b00430","article-title":"PET imaging of (18)F-(2 S,4 R)4-Fluoroglutamine accumulation in breast cancer: from xenografts to patients","volume":"15","author":"Liu","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2019.111730_bib34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2967\/jnumed.112.108704","article-title":"(4S)-4-(3-18F-fluoropropyl)-L-glutamate for imaging of xC transporter activity in hepatocellular carcinoma using PET: preclinical and exploratory clinical studies","volume":"54","author":"Baek","year":"2013","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ejmech.2019.111730_bib35","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2310\/7290.2010.00025","article-title":"Click synthesis and biologic evaluation of (R)- and (S)-2-amino-3-[1-(2-[18F]fluoroethyl)-1H-[1,2,3]triazol-4-yl]propanoic acid for brain tumor imaging with positron emission tomography","volume":"9","author":"McConathy","year":"2010","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.ejmech.2019.111730_bib36","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.7150\/thno.22083","article-title":"Amino acid uptake measured by [(18)F]AFETP increases in response to arginine starvation in ASS1-deficient sarcomas","volume":"8","author":"Prudner","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.ejmech.2019.111730_bib37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cell.2016.02.035","article-title":"The CASTOR proteins are arginine sensors for the mTORC1 pathway","volume":"165","author":"Chantranupong","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2019.111730_bib38","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/jcb.23022","article-title":"CAT-1-mediated arginine uptake and regulation of nitric oxide synthases for the survival of human breast cancer cell lines","volume":"112","author":"Abdelmagid","year":"2011","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.ejmech.2019.111730_bib39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nature19079","article-title":"Mechanism of arginine sensing by CASTOR1 upstream of mTORC1","volume":"536","author":"Saxton","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.111730_bib40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3945\/jn.115.226621","article-title":"Arginine metabolism revisited","volume":"146","author":"Morris","year":"2016","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.ejmech.2019.111730_bib41","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/ajcn\/81.5.1142","article-title":"Plasma arginine concentrations are reduced in cancer patients: evidence for arginine deficiency?","volume":"81","author":"Vissers","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ejmech.2019.111730_bib42","first-page":"5443","article-title":"Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in\u00a0vitro and in\u00a0vivo","volume":"62","author":"Ensor","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2019.111730_bib43","doi-asserted-by":"crossref","first-page":"8432","DOI":"10.1021\/jo9814344","article-title":"Triurethane-protected guanidines and triflyldiurethane-protected Guanidines:\u2009 new reagents for guanidinylation reactions","volume":"63","author":"Feichtinger","year":"1998","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2019.111730_bib44","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1021\/jo7021229","article-title":"Facile nucleophilic fluorination reactions using tert-alcohols as a reaction medium: significantly enhanced reactivity of alkali metal fluorides and improved selectivity","volume":"73","author":"Kim","year":"2008","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2019.111730_bib45","doi-asserted-by":"crossref","first-page":"16394","DOI":"10.1021\/ja0646895","article-title":"A\u00a0new class of SN2 reactions catalyzed by protic Solvents:\u2009 facile fluorination for isotopic labeling of diagnostic molecules","volume":"128","author":"Kim","year":"2006","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2019.111730_bib46","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/jcb.23022","article-title":"CAT-1-mediated arginine uptake and regulation of nitric oxide synthases for the survival of human breast cancer cell lines","volume":"112","author":"Abdelmagid","year":"2011","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.ejmech.2019.111730_bib47","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1093\/jn\/134.10.2752S","article-title":"Plasma membrane transporters for arginine","volume":"134","author":"Closs","year":"2004","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.ejmech.2019.111730_bib48","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.mam.2012.10.007","article-title":"The SLC3 and SLC7 families of amino acid transporters","volume":"34","author":"Fotiadis","year":"2013","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.ejmech.2019.111730_bib49","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00232-006-0875-7","article-title":"Structure and function of cationic amino acid transporters (CATs)","volume":"213","author":"Closs","year":"2006","journal-title":"J.\u00a0Membr. Biol."},{"key":"10.1016\/j.ejmech.2019.111730_bib50","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/0003-9861(76)90558-0","article-title":"Metabolism of absorbed aspartate, asparagine, and arginine by rat small intestine in\u00a0vivo","volume":"175","author":"Windmueller","year":"1976","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2019.111730_bib51","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00000658-199309000-00014","article-title":"Arginine transport in human liver. Characterization and effects of nitric oxide synthase inhibitors","volume":"218","author":"Inoue","year":"1993","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ejmech.2019.111730_bib52","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00726-014-1754-7","article-title":"Synthesis and preliminary biological evaluation of O-2((2-[(18)F]fluoroethyl)methylamino)ethyltyrosine ([(18)F]FEMAET) as a potential cationic amino acid PET tracer for tumor imaging","volume":"46","author":"Chiotellis","year":"2014","journal-title":"Amino Acids"},{"key":"10.1016\/j.ejmech.2019.111730_bib53","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.2967\/jnumed.111.093815","article-title":"PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine","volume":"52","author":"Lieberman","year":"2011","journal-title":"J.\u00a0Nucl. Med."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419308827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419308827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:05:44Z","timestamp":1759327544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419308827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":53,"alternative-id":["S0223523419308827"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111730","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of [18F](2S,4S)4-(3-fluoropropyl) arginine as a tumor imaging agent","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111730","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111730"}}